bioRxivEvolutionary BiologyPreprint
The Kishony Mega-Plate Experiment, a Markov Process
Abstract
A correct understanding of the DNA evolution of drug resistance is critical in developing strategies for suppressing and preventing this process. The Kishony Mega-Plate Experiment demonstrates this important phenomenon that occurs in the practice of medicine, that of the evolution of drug-resistance. The evolutionary process which the bacteria in this experiment are doing is called a Markov Process or Markov Chain. Understanding this process enables clinicians and researchers to predict the evolution of drug-resistance and develop strategies to prevent this process. This paper will show how to apply the Markov Chain model of DNA evolution to the Kishony Mega-Plate Experiment and why the experiment behaves the way it does by contrasting the Jukes-Cantor model of DNA evolution (a stationary model) with a modification of the Jukes-Cantor model that makes it a non-stationary, non-equilibrium Markov Chain. The numerical behaviors of the stationary and non-stationary models are compared. What this analysis shows is that DNA evolution is a non-stationary, non-equilibrium process and that by using the correct non-stationary, non-equilibrium model that one can simulate and predict the behavior of real evolutionary examples and that these analytical tools can give the clinician guidance on how to use antimicrobial selection pressures for treating infectious diseases. This in turn can help reduce the numbers and costs of hospitalization for sepsis, pneumonia and other infectious diseases.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Exploiting evolutionary non-commutativity to prevent the emergence of bacterial antibiotic resistance
Daniel Nichol, Peter Jeavons, … Jacob G Scott·PLOS Computational BiologyPeer-reviewed·Sep 11, 2015
- Simple theoretical models predict some - but not all - aspects of the experimental evolution of antibiotic resistance
Elin Lilja, Rosalind J. Allen, Bartłomiej Waclaw·bioRxiv·Sep 7, 2025
- Fitness landscapes reveal simple strategies for steering evolution to minimize antibiotic resistance
Maria Smith, Sarah Cobey·bioRxiv·Dec 11, 2016
- Drug mode of action and resource constraints modulate antimicrobial resistance evolution
O. Delaney, A. D. Letten, J. Engelstädter·bioRxiv·Aug 29, 2023
- Non-monotonic Relationship between Mutation Rate and Speed of adaptation under Antibiotic Exposure in Escherichia coli
A. Shibai, M. Izutsu, … C. Furusawa·bioRxiv·Aug 15, 2023
- Probability of Antibiotic Resistance During Treatment in Stochastic PK/PD-Based Bacterial Model with Distinct Drug and Mutation Modes
Chimezie Izuazu, Cameron J. Browne·Bulletin of Mathematical BiologyPeer-reviewed·Sep 3, 2026